Home › Companies › LifeStance Health Group, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and LifeStance Health Group, Inc.’s Form 8-K, filed 2026-06-04 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore LifeStance Health Group, Inc. in the interactive database Compare manager voting policies
These tallies are LifeStance Health Group, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: David Bourdon | 244,968,319 | -- | -- | 83,966,052 | 29,782,714 | Majority: yes |
| Elect Director: Robert Bessler | 280,015,618 | -- | -- | 48,918,753 | 29,782,714 | Majority: yes |
| Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ended Decem | 357,756,707 | 209,431 | 750,947 | -- | -- | Majority: yes |
| Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company's named executive officer compensation | 322,904,359 | 5,675,861 | 354,151 | -- | 29,782,714 | Majority: yes |
Source: LifeStance Health Group, Inc., Form 8-K, filed with the SEC on 2026-06-04 — read the filing on EDGAR.
Each item below shows how the 216 asset managers that disclosed a LifeStance Health Group, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
LifeStance Health Group, Inc.’s own tally for this item (“Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company's named executive officer compensation”): 322,904,359 for, 5,675,861 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 387,813,000 outstanding shares: 83% for, 1% against (85% of the company cast a for/against vote).
The 214 asset managers below cast 98% of the shares they voted on this item FOR (213,348,794 for, 4,470,322 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 115,400,899 | 0 | 0 | 0 | For |
| Vanguard | 19,099,636 | 16 | 1 | 0 | For |
| BlackRock | 15,242,933 | 68,574 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 9,763,367 | 53,328 | 0 | 0 | For |
| Prudential/PGIM | 5,488,312 | 0 | 0 | 0 | For |
| Dimensional | 4,922,786 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,730,901 | 0 | 0 | 0 | For |
| State Street | 3,777,617 | 784 | 0 | 0 | For |
| Charles Schwab | 3,088,476 | 0 | 0 | 0 | For |
| UBS | 0 | 2,595,011 | 0 | 0 | Against |
| Integral Health Asset Management, LLC | 2,445,952 | 0 | 0 | 0 | For |
| Nuveen | 2,210,932 | 0 | 0 | 0 | For |
| TIAA | 2,179,245 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 1,936,702 | 0 | 0 | 0 | For |
| Loomis Sayles | 1,886,324 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,775,053 | 0 | 0 | 0 | For |
| Putnam | 1,658,088 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 1,610,466 | 0 | 0 | 0 | For |
| Northern Trust | 1,449,979 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,400,785 | 0 | 0 | 0 | For |
| Principal | 1,159,930 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,138,082 | 0 | 0 | 0 | For |
| First Trust | 792,977 | 0 | 0 | 0 | For |
| SEI | 741,181 | 0 | 0 | 0 | For |
| AQR | 657,637 | 0 | 0 | 0 | For |
Showing the 25 largest of 214 asset managers. See all 214 in the interactive database.
Combines 4 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
LifeStance Health Group, Inc.’s own tally for this item (“Elect Director: David Bourdon”): 244,968,319 for, 83,966,052 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 387,813,000 outstanding shares: 63% for, 22% withheld (85% of the company cast a for/withheld vote).
The 65 asset managers below cast 100% of the shares they voted on this item FOR (40,630,973 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,357,366 | 0 | 52,653,118 | 0 | Abstain |
| Vanguard | 17,528,334 | 0 | 261 | 0 | For |
| BlackRock | 7,390,880 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,846,654 | 0 | 33,203 | 0 | For |
| Dimensional | 0 | 0 | 3,763,194 | 0 | Abstain |
| TIAA | 2,179,245 | 0 | 0 | 0 | For |
| Charles Schwab | 1,543,508 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 0 | 0 | 1,400,785 | 0 | Abstain |
| Principal | 0 | 0 | 1,159,930 | 0 | Abstain |
| Putnam | 0 | 0 | 828,900 | 0 | Abstain |
| First Trust | 0 | 0 | 792,977 | 0 | Abstain |
| Equitable | 368,752 | 0 | 0 | 0 | For |
| Goldman Sachs | 345,238 | 0 | 0 | 0 | For |
| State Street | 303,963 | 0 | 676 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 267,957 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 254,365 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 239,615 | 0 | Abstain |
| MERIDIAN FUND INC | 215,038 | 0 | 0 | 0 | For |
| Mercer Funds | 0 | 0 | 193,729 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 191,892 | 0 | Abstain |
| Lincoln Financial | 96,700 | 0 | 80,255 | 0 | For |
| Northern Trust | 141,631 | 0 | 0 | 0 | For |
| Global X | 112,545 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 112,266 | 0 | 0 | 0 | For |
| Invesco | 110,031 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
LifeStance Health Group, Inc.’s own tally for this item (“Elect Director: Robert Bessler”): 280,015,618 for, 48,918,753 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 387,813,000 outstanding shares: 72% for, 13% withheld (85% of the company cast a for/withheld vote).
The 65 asset managers below cast 100% of the shares they voted on this item FOR (82,447,738 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 56,731,875 | 0 | 278,609 | 0 | For |
| Vanguard | 17,511,092 | 0 | 17,504 | 0 | For |
| BlackRock | 0 | 0 | 7,390,880 | 0 | Abstain |
| Prudential/PGIM | 4,846,654 | 0 | 33,203 | 0 | For |
| Dimensional | 0 | 0 | 3,763,194 | 0 | Abstain |
| TIAA | 0 | 0 | 2,179,245 | 0 | Abstain |
| Charles Schwab | 1,543,508 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 0 | 0 | 1,400,785 | 0 | Abstain |
| Principal | 0 | 0 | 1,159,930 | 0 | Abstain |
| Putnam | 0 | 0 | 828,900 | 0 | Abstain |
| First Trust | 0 | 0 | 792,977 | 0 | Abstain |
| Equitable | 0 | 0 | 368,752 | 0 | Abstain |
| Goldman Sachs | 345,238 | 0 | 0 | 0 | For |
| State Street | 257 | 0 | 304,382 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 267,957 | 0 | Abstain |
| Northern Lights Fund Trust IV | 254,365 | 0 | 0 | 0 | For |
| Loomis Sayles | 239,615 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 215,038 | 0 | 0 | 0 | For |
| Mercer Funds | 193,729 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 191,892 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 176,955 | 0 | Abstain |
| Northern Trust | 0 | 0 | 141,631 | 0 | Abstain |
| Global X | 112,545 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 112,266 | 0 | Abstain |
| Invesco | 110,031 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Combines 7 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
LifeStance Health Group, Inc.’s own tally for this item (“Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public ”): 357,756,707 for, 209,431 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 387,813,000 outstanding shares: 92% for, 0.1% against (92% of the company cast a for/against vote).
The 65 asset managers below cast 100% of the shares they voted on this item FOR (102,596,277 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 57,010,484 | 0 | 0 | 0 | For |
| Vanguard | 17,528,595 | 0 | 1 | 0 | For |
| BlackRock | 7,390,880 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,879,857 | 0 | 0 | 0 | For |
| Dimensional | 3,763,194 | 0 | 0 | 0 | For |
| TIAA | 2,179,245 | 0 | 0 | 0 | For |
| Charles Schwab | 1,543,508 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 1,400,785 | 0 | 0 | 0 | For |
| Principal | 1,159,930 | 0 | 0 | 0 | For |
| Putnam | 828,900 | 0 | 0 | 0 | For |
| First Trust | 792,977 | 0 | 0 | 0 | For |
| Equitable | 368,752 | 0 | 0 | 0 | For |
| Goldman Sachs | 345,238 | 0 | 0 | 0 | For |
| State Street | 304,639 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 267,957 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 254,365 | 0 | 0 | 0 | For |
| Loomis Sayles | 239,615 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 215,038 | 0 | 0 | 0 | For |
| Mercer Funds | 193,729 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 191,892 | 0 | 0 | 0 | For |
| Lincoln Financial | 176,955 | 0 | 0 | 0 | For |
| Northern Trust | 141,631 | 0 | 0 | 0 | For |
| Global X | 112,545 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 112,266 | 0 | 0 | 0 | For |
| Invesco | 110,031 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.
Ranked by the number of LifeStance Health Group, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 387,813,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 29.76% |
| 2 | Vanguard | 4.92% |
| 3 | BlackRock | 3.95% |
| 4 | JENNISON ASSOCIATES LLC | 2.53% |
| 5 | Prudential/PGIM | 1.42% |
| 6 | Dimensional | 1.27% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.22% |
| 8 | State Street | 0.97% |
| 9 | Charles Schwab | 0.80% |
| 10 | UBS | 0.67% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Parties to the Stockholders Agreement | 43.64% | DEF14A |
| TPG VIII Lynnwood Holdings Aggregation, L.P. | 36.11% | DEF14A |
| TPG GP A, LLC | 25.30% | 13G |
| FMR (Fidelity) | 15.13% | 13F |
| FMR, LLC | 12.04% | DEF14A |
| Summit Partners and affiliates | 7.53% | DEF14A |
| Summit Partners, L.P. | 6.01% | 13G |
| BlackRock | 4.68% | 13F |
| Vanguard Group | 4.56% | 13F |
| Dimensional Fund Advisors | 2.67% | 13F |
Percentages above are of 387,813,000 shares outstanding, as reported by LifeStance Health Group, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LifeStance Health Group, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At LifeStance Health Group, Inc.'s shareholder meeting held 2026-06-02, in the 2025-2026 proxy season, 216 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,172 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the Company's named executive officers; — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LifeStance Health Group, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-04.
LifeStance Health Group, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).